Merck & Co Inc (MRK) has a current Price-to-Book (P/B) ratio of 5.11. Compared to its 3-year average P/B ratio of 6.08, the current P/B ratio is approximately -15.96% higher. Relative to its 5-year average P/B ratio of 5.99, the current P/B ratio is about -14.67% higher. Merck & Co Inc (MRK) has a Forward Free Cash Flow (FCF) yield of approximately 4.94%. Compared to its 3-year average FCF yield of 4.94%, the current FCF yield is approximately 0.05% lower. Relative to its 5-year average FCF yield of 4.90%, the current FCF yield is about 0.88% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for MRK competitors is 4.60, providing a benchmark for relative valuation. Merck & Co Inc Corp (MRK.N) exhibits a P/S ratio of 3.95, which is -13.97% above the industry average. Given its robust revenue growth of 4.97%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of MRK increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of MRK in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is MRK currently overvalued or undervalued?

What is Merck & Co Inc (MRK) fair value?

MRK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Merck & Co Inc (MRK) is between 67.93 to 304.54 according to relative valuation method.

How does MRK's valuation metrics compare to the industry average?

The average P/S ratio for MRK's competitors is 4.60, providing a benchmark for relative valuation. Merck & Co Inc Corp (MRK) exhibits a P/S ratio of 3.95, which is -13.97% above the industry average. Given its robust revenue growth of 4.97%, this premium appears unsustainable.

What is the current P/B ratio for Merck & Co Inc (MRK) as of Mar 03 2026?

As of Mar 03 2026, Merck & Co Inc (MRK) has a P/B ratio of 5.11. This indicates that the market values MRK at 5.11 times its book value.

What is the current FCF Yield for Merck & Co Inc (MRK) as of Mar 03 2026?

As of Mar 03 2026, Merck & Co Inc (MRK) has a FCF Yield of 4.94%. This means that for every dollar of Merck & Co Inc's market capitalization, the company generates 4.94 cents in free cash flow.

What is the current Forward P/E ratio for Merck & Co Inc (MRK) as of Mar 03 2026?

As of Mar 03 2026, Merck & Co Inc (MRK) has a Forward P/E ratio of 12.32. This means the market is willing to pay $12.32 for every dollar of Merck & Co Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Merck & Co Inc (MRK) as of Mar 03 2026?

As of Mar 03 2026, Merck & Co Inc (MRK) has a Forward P/S ratio of 3.95. This means the market is valuing MRK at $3.95 for every dollar of expected revenue over the next 12 months.

MRK Valuation